Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate for "TRUE Test® Panel 3" - a Phase II, Dose-Response Study.

NCT00133341 is registered in ClinicalTrials.gov with Mekos Laboratories AS as lead sponsor.

NCT NCT00133341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate for "TRUE Test® Panel 3" - a Phase II, Dose-Response Study.
Lead sponsor
Mekos Laboratories AS
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
December 31, 2005
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic contact dermatitis